We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Modified Trocar Helps Avert Laparoscopic Surgery Injuries

By HospiMedica International staff writers
Posted on 05 Jan 2015
Image: Prototype of the new trocar for laparoscopic procedures (Photo courtesy of Nottingham Trent University).
Image: Prototype of the new trocar for laparoscopic procedures (Photo courtesy of Nottingham Trent University).
A new trocar for laparoscopic procedures uses an automatic needle safety mechanism which causes it to withdraw the moment it enters the abdominal cavity.

Developed by researchers at Nottingham Trent University (NTU; United Kingdom) and Olberon Medical Innovations (Loos, France), the modified trocar is based on a mechanism which monitors changes in the pressure of the insertion, and inflates a diaphragm which activates its own withdrawal by the force of a tiny spring, after it passes through the muscle and tissue.

“It’s imperative that the trocar is improved to help avoid the kinds of accidents which can cause serious and fatal injuries, no matter how rare,” said Prof. Amin Al-Habaibeh, PhD, of the NTU school of architecture, design, and the built environment, who developed the trocar together with research assistant Joaquim Justino Netto, a student from Brazil on placement as part of the Science Without Borders scholarship. “This simple invention could be an important tool which prevents accidents and enables surgeons to carry out this routine procedure with increased confidence at a lower risk of injury to the patient.”

“This advanced trocar is a significant improvement on existing products and highlights the importance of industry working with academia,” said Arash Bakhtyari, MD, managing director of Olberon Medical Innovations. “Through the longstanding and successful collaboration with Nottingham Trent University, we have developed a novel medical invention which has the potential to help doctors and patients around the world.”

Although complications are rare, bowel perforations or bile duct injuries which remain undiagnosed until after surgery can result in life threatening complications such as circulatory collapse or septic shock. Data from the UK National Patient Safety Agency (London, United Kingdom) shows that between 2003 and 2010, there were 48 serious incidents relating to laparoscopic surgery, including 11 deaths.

Related Links:

Nottingham Trent University
Olberon Medical Innovations
National Patient Safety Agency


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
High-Precision QA Tool
DEXA Phantom
New
Patient Monitor
IntelliVue MP5SC

Channels

Critical Care

view channel
Image: Researchers have taken a major step toward cuff-free blood pressure monitoring (Photo courtesy of Gwyneth Moe/Boston University)

Cuff-Free Blood Pressure Monitoring Device to Improve Early Detection and Management of Hypertension

Hypertension affects nearly half of all adults in the U.S. and remains the leading cause of cardiovascular disease. Regular and accurate blood pressure monitoring is essential for managing this condition,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more